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Abstract  
The application of treated sewage sludge on farmland is a suggested method for recycling 
nutrients and reducing demand for commercial fertilizer. However sludge needs to be 
rendered safe from possible contaminants which can cause acute and long-term health and 
environmental problems. Residual pharmaceuticals and organic contaminants in sludge are 
mentioned as emerging threats since wastewater treatment plants are not designed to degrade 
these substances thus yielding an accumulation in sludge. The aim of this study was to 
evaluate the presence, and reduction, of pharmaceuticals and polycyclic aromatic 
hydrocarbons (PAHs) during anaerobic digestion at 35, 55 and 60ºC and during pasteurization 
at 70°C. The substrate used was mixed primary and secondary sludge from a 300 000 person-
equivalents municipal wastewater treatment plant in southern Sweden. In general no reduction 
of pharmaceuticals could be observed at any temperature or minimum exposure time, except 
for the beta-blocker Irbesartan and the antibiotic Trimethoprim. The results from 
pharmaceuticals in mesophilic sludge agreed with results in recent Swedish studies. Also, no 
reduction of PAHs during digestion or pasteurization (70°C – 1 hour) was seen, but for single 
PAHs digestion could lead to reduction.  
 




To be able to apply treated sewage sludge on farmland for recycling of nutrients and reducing 
demand for commercial fertilizer the sludge need to be rendered safe from possible 
contaminants which can cause health and environmental problems. Pathogens, residual 
pharmaceuticals and organic contaminants in sludge are mentioned as emerging threats since 
wastewater treatment plants (WWTPs) are not designed to degrade or mineralise these 
substances thus yielding an accumulation in sludge (Naturvårdsverket, 2008).  
 
Polycyclic aromatic hydrocarbons (PAH) and polychlorinated bi-phenyls (PCB) are 
micropollutants with known toxic and carcinogenic properties both for humans and aquatic 
organisms (Økland et al., 2005). The groups include some hardly degradable compounds with 
long degradation times (Naturvårdsverket, 2003; Økland et al., 2005). The proposal for a new 
EU Water Framework Directive (WFD) (EC, 2012) is mostly focused on the PAHs since the 
use of PCBs is banned and the PCB concentrations in sludge has been seen to decrease the 
latest decades in both EU and other parts of the world (Clarke et al., 2008; Clarke et al., 2010; 
Erhardt & Prüeß, 2001). The studies by Clarke et al. (2008, 2010) also showed that the 
degradation is increased with a higher temperature and that some PAHs were more efficiently 
removed at thermophilic digestion. In Trably et al. (2003) it was shown that the removal 
efficiency correlated with the methanogenic activity.  
 
Environmental effects from pharmaceutical residues in wastewater are of great interest since  
humans excrete pharmaceuticals and their metabolites, which can possibly end up in the  
environment with the treated wastewater (to recipients) or as sludge being used as fertilizer on 
agricultural land. Effects on aquatic organisms in recipients have been seen from endocrine 
disruptors and eventual increase of resistance to antibiotics on bacteria caused by residues in 
wastewater effluents or re-used sludge is discussed at the moment.  No statutory limit 
concentrations for pharmaceutical residues in effluent wastewater or stabilised sludge from 
WWTPs exist, but the proposal for a new EU WFD suggest to keep track of Diclofenac, 
Ethinylestradiol and Estradiol (EC, 2012). 
 
There are two possibilities to make the sludge less harmful for the environment and possible 
to re-use as fertiliser: 1) the contaminants can be avoided in the original wastewater by up-
stream work (mitigation near the source of the pollution e.g. by reducing industrial 
discharges, local treatment at hospitals and by educating inhabitants) and 2) the contaminants 
could possibly be reduced/degraded in the sludge treatment processes at the WWTP, such as 
the anaerobic digestion or, if occurring, a separate hygienization step or other pre/post-
treatment methods. This study has focused on finding out the potential of the second 
possibility by evaluating the presence and reduction of 99 pharmaceuticals and 15 PAHs in 
sludge during anaerobic digestion at 35, 55 and 60ºC. These analyses were made in 
connection to measuring the pathogen reduction after continuous digestion at different 
temperatures with different minimum exposure times (time between feeding). Included in the 
study was also a separate hygienization step in form of pasteurization at 70°C for 1 hour, 
which has been suggested as a means of reducing pathogens in sludge; more details are found 
in Kjerstadius et al. (2013). The substrate used was mixed primary and waste activated sludge 




Sludge consisting of a mix of primary sludge (25%) and biological sludge (75%) from the 
Sjölunda Wastewater treatment plant in Malmö, Sweden was pasteurized at 70°C for 1 hour 
or digested in anaerobic reactors.  
 
The anaerobic digestion test setup was a series of 20 L semi-continuously fed  stirred-tank 
reactors (CSTR’s), each set to a combination of temperatures (35, 55 and 60ºC) and hydraulic 
retention times (7 and 15 days). At steady-state conditions and after minimum exposure times 
of 2, 2.5, 6 and 24 hours samples were removed and analyzed for concentration of the 
pharmaceutical substances and PAHs. Minimum exposure time is here defined as the time 
between feeding of new sludge and withdrawal of digested residue used when operating the 
semi-continuously fed digesters. Pasteurization of sludge was done by heating up raw sludge 
during 30 min in water bath and then keeping it at 70ºC for 1 hour. Total solids (TS) and 
volatile solids (VS) were determined according to DS/EN 872:1997. 
 
Pharmaceutical residues 
All sludges were freeze-dried and 0.1 g (dry weight) sample aliquots were used for extraction, 
to which internal and surrogate standards were added before extraction. Sequential extraction 
was performed using ethyl acetate and methanol (1:1) followed by methanol and water (7:3) 
with 5% triethylamine. Samples were homogenized for four minutes, at 42000 oscillations per 
minute, using a Mini Beadbeater (Biospec. Bartlesville, USA) with zirconium beads and then 
centrifuged at 14000 rpm for 10 min. This protocol was done for both eluent mixtures and the 
supernatants were combined, evaporated to 20 µL and reconstituted in 1 ml water and 
acetonitrile (95:5 mixture) with 0.1% formic acid. 
 
All pharmaceuticals were analyzed with the same methodology as reported in Grabic et al. 
(2012). In short, a triple stage quadrupole MS/MS TSQ Quantum Ultra EMR (Thermo Fisher 
Scientific, San Jose, CA, USA) coupled with an Accela LC pump (Thermo Fisher Scientific, 
San Jose, CA, USA) and a PAL HTC autosampler (CTC Analytics AG, Zwingen, 
Switzerland) were used as analytical system. Twenty µL of the sample was loaded onto a 
Hypersil GOLD aQ TM column (50 mm x 2.1 mm ID x 5 µm particles, Thermo Fisher 
Scientific, San Jose, CA, USA) preceded by a guard column (2 mm×2.1 mm i.d, 5 µm 
particles) of the same packing material and from the same manufacturer. Both heated 
electrospray (HESI) and atmospheric pressure photoionization (APPI) in positive and 
negative ion modes were used for ionization of target compounds. The same method was used 
to investigate the fate of APIs in wastewater treatment by Hörsing et al. (2011) and Hey et al. 
(2012) and a full method evaluation and detailed description is given in Grabic et al. (2012).  
  
Polycyclic aromatic hydrocarbons  
The sludge samples (digested, pasteurized and untreated sludge from the four test rounds with 
minimum exposure times 24h, 6h, 2h and 2.5h) were freeze-dried and then stored in 4°C until 
analysis. Microwave assisted extraction of 0.5 g freeze-dried sludge was performed in a 
Multiwave 3000SOLV, Anton-Paar using hexane and acetone (3:2). Thereafter the extracts 
were filtrated through glass wool and 2 ml isooctane (2,2,4-trimethylpentane), containing 100 
µg/l naphthalene-d8, pyrene-d10 and phenantrene-d10 as internal standards were added 
before evaporation to 2 ml (with N2 or compressed air). Conditioned solid phase (SPE) 
columns (LC-Florisil) were used for concentration and clean-up and the analytes were eluted 
by hexane and toluene (4:1). SPE-extracts were evaporated to 2 ml and transferred to GC-MS 
vials. GC-MS was used for separation and detection of all PAHs simultaneously in each 
sample. 15 of the US EPA list of 16 PAHs were determined (acenaphthene, acenaphtylene, 
anthracene, benzo[a]antracene, benzo[a]Pyrene, benzo[b]fluoranthene, benzo[g,h,i]perylene, 
chrysene, dibenzo[a,h]anthracene, fluoranthene, fluorene, indeno[1,2,3-cd]perylene, 
naphthalene, phenanthrene and pyrene). 
 
 
RESULTS AND DISCUSSION 
Pharmaceutical residues 
In total 99 pharmaceutical substances were analysed (in duplicates or triplicates) in sludge 
samples (untreated, pasteurized (1h - 70°C) and digested at 35, 55, 60°C with different 
minimum exposure times). Some (72) of the substances were found in at least one sludge 
sample, but only 19 of the substances were found in both untreated, pasteurized and digested 
sludge. Average measured concentrations of chosen substances are presented in Table 1, 
together with standard deviations to show the difficulty of measuring such low concentrations 
in the sludge matrix. Chosen substances are two of the ones mentioned in the water frame 
work directive proposal (Diclofenac and Ehinylestradiol), substances that are heavily 
deviating from other reported values in literature (Fick, 2011; Wahlberg, 2010) (Bupropion, 
Ciprofloxacin and Miconazole), substances occurring in highest concentrations 
(Ciprofloxacin, Dipyridamol, Sertraline, Irbesartan and Ketoconazole) and substances that 
seem to be reduced during anaerobic digestion (Irbesartan and Trimethoprim). 
 
Table 1- Average values and standard deviation (in italic) of chosen pharmaceutical 
substances in sludges (untreated, digested and pasteurized);unit: ng/g TS. Digested sludges 
with 24 hours exposure time. N=2 for all samples except 70°C, 60 min, where N=3. The total 




(4.9 % TS) 
35°C,  
15 days HRT 
(2.0 % TS) 
55°C,  
15 days HRT 
(2.1 % TS) 
60°C,  
15 days HRT 
(2.3 % TS) 
70°C,  
60 min  
(4.9 % TS) 
Diclofenac
*
 <10 - <10 - <10 - <10 - <10 - 
Ethinylestradiol
*
 <10 - <10 - <10 - <10 - <10 - 
Bupropion 5 1 13 6 52 10 13 3 5 3 
Ciprofloxacin 2 100 800 4 100 600 1 500 30 1 400 500 2 400 570 
Miconazole 36 - 19 13 50 30 10 - 10 3 
Ciprofloxacin 2 100 800 4 100 600 1 500 40 1 400 500 2 400 570 
Dipyridamol 190 130 490 30 470 270 320 10 190 30 
Sertraline 280 10 670 40 810 250 180 110 340 110 
Irbesartan 1 900 2 600 540 380 20 20 60 10 240 100 
Ketoconazole 200 60 160 50 220 90 90 0 110 - 
Irbesartan 1 900 2 600 540 380 20 20 60 10 240 100 
Trimethoprim 19 21 <0.1 - 1 0 5 0 30 20 
*  
Limit of quantification 10 ng/g TS 
  
In general no reduction of pharmaceuticals could be observed at any temperature or minimum 
exposure time, except for Irbesartan and Trimethoprim. Irbesartan (blood pressure lowering 
substance) was seen to be reduced by pasteurization or anaerobic digestion (Table 1) with 
higher reduction for thermophilic digestion. Trimethoprim (antibiotic substance) was reduced 
by anaerobic digestion but not by pasteurization. The concentrations of pharmaceuticals in the 
mesophilic sludge agreed well with results in recent studies on Swedish sludges (Wahlberg et 
al., 2010; Fick et al., 2011). Some substances seem to increase in concentration during 
digestion. This indicates a high uncertainty of the method resulting in high standard 
deviations or that the substances actually occur in higher concentrations after digestion. The 
uncertainty in the method is a probable reason, because in 70% of the cases with increasing 
concentrations after digestion, the standard deviations are really high for both concentrations 
in untreated and digested sludge. If the substances actually occur in higher concentrations 
after digestion there are two possibilities: The digestion may lead to extraction of 
pharmaceuticals from the sludge by reduction of the particles on which the pharmaceuticals 
can adsorb. The other reason could be that degradation products, that has been released in 
conjugated form after metabolization in the human body and then ended up in wastewater 
entering the WWTP, can be recreated to the mother substance. This phenomenon has been 
discussed for wastewater in other studies (Naturvårdsverket, 2008; Wahlberg et al., 2010) 
High standard deviations (13-118%) for the results were seen both for samples analysed in 
duplicate and triplicate and are explained by the difficulties of making analyses of the sludge 
matrix. Recovery tests performed by the same lab as in the study on both wastewater and 
sludges showed in general lower degrees of recovery and higher standard deviations for 
sludge. More reliable analysis methods for sludge are consequently needed.  
 
Polycyclic aromatic hydrocarbons  
Samples were analysed in duplicates and certified reference materials in triplicates, yielding 
relative standard deviations (RSD) of 2-17%, and recoveries of 98-112% 
(benzo[g,h,i]perylene, dibenzo[a,h]anthracene, indeno[1,2,3-cd]perylene, and naphthalene, 
i.e., the lightest and the heaviest PAHs had the same excellent RSD 5-18% and, as expected, 
lower recoveries of 25-32%).  
 
Out of the 15 PAH analysed, 11 were detected and quantified. Fluoranthene (0.15-0.66 mg/kg 
TS), phenanthrene (0.10-0.49) and pyrene (0.13-0.56) were the 3 PAHs detected in all 
samples. Anthracene, benzo[a]anthracene and fluorene were present in only a few samples 
above the quantification limi (1, 3 and 8 samples out of 28 analysed). Benzo[b]fluoranthene, 
benzo[g,h,i]perylene, chrysene, dibenzo[a,h]anthracene and indeno[1,2,3-cd]perylene were 
also detected above the detection limits. The summary concentrations of the 8 PAHs 
(anthracene, benzo[a]pyrene, benzo[b]fluoranthene, benzo[g,h,i]perylene, fluoranthene, 
indeno[1,2,3-cd]perylene and naphthalene) included in the proposal for the new WFD (EC, 
2012) are found in Table 2.  
 
Table 2. Summary concentrations of PAH-7* mentioned in the WFD proposal (2012) in the 





















24 1.7 1.8 2.3 2.3 2.5 2.3 2.8 
6 1.6 1.6 2.4 2.3 2.5 2.3 2.3 
2.5 1.6 1.7 2.5 2.2 2.4 2.3 2.4 
2 1.4 1.7 2.4 2.1 2.2 2.1 2.2 
*benzo[k]fluoranthene was not measured, but dibenzo[a,h]anthracene was included 
 
The results show that no statistical significant reduction of the sum of PAH was achieved 
during digestion or pasteurization, a result that is also valid for several of the individual PAHs 
in the study. For single PAHs reduction up to 60% during digestion was seen, namely, for 
indeno[1,2,3-cd]pyrene  and dibenzo[a,h]antracene (analysed as sum) and for 
benzo[g,h,i]perylene, see Figure 1. Digestion at 35 and 55°C resulted in similar reduction of 
these 3 PAHs while digestion at 60°C resulted in lower reduction. No statistical correlation 
between reduction and exposure time was seen. No reduction of the 3 PAHs was seen during 
pasteurization. The total concentration of sum PAH (1.4-2.8 mg/kg TS) was high compared to 
the results found in Olofsson et al. (2013), where sludge from seven Swedish WWTP:s were 
analysed (ranging from 0.47-1.7 mg/kg TS).  
 
Reduction of the same 3 heavy PAH was also seen in a study by Trably et al. (2003) but in 
that study was also seen reduction of other PAHs which could be explained by the long HRT 
(41 days) used in their digestion tests, since a long retention time may lead to an increased 
degradation. However, no significant difference in reduction between the different HRT:s (7 
days and 15 days) applied in this study was seen. In Christensen et al. (2004) naphthalene was 
reduced during digestion with much longer exposure time than in this study. Higher reduction 
at longer exposure times could be explained by a favouring of PAH reduction when easily 
degradable matter already has been consumed. This reasoning is supported by the results in 
Trably et al. (2003) which showed that the PAH reduction increased when the biogas 
production decreased. Alternatively the decrease in gas production could be a result of 
inhibition of methanogens from the increase of hydrogen produced during degradation of 
PAH shown by Christensen et al. (2004). The latter is more unlikely since the hydrogen 
production from reduction of PAH should be insignificant compared to the other hydrogen 




Figure 1. Reduction of 3 PAH (indeno[1,2,3-cd]pyrene and dibenzo[a,h]antracene (analysed 
as group) and benzo[g,h,i]perylene) during digestion and pasteurization.  
 
The influence of digestion temperature on reduction is contradictory to other studies. The 
results for the 3 PAH that were reduced showed that the reduction was lower at 60°C than at 
35°C or 55°C. Christensen et al. (2004) and Trably et al. (2003) state that the reduction is 
increased with an increased temperature and with an adjusted microbial population. A 
possible explanation to the lower reduction seen at 60°C could be a sub-optimal microbial 
population of the anaerobic digestion metabolism deriving from the higher temperature of 
digestion. Such a hypothesis is supported by the fact that methane production was 10% less in 
reactors operated at 60°C than at 55°C (Kjerstadius et al., 2013). This effect was contributed 
to the shift in methanogenic genera from methanosarcina to methansaeta which occurs around 
60-62°C (Van Lier et al., 1993; Zinder, 1990; Zehnder, 1988). However since the complete 
degradation pathway of PAH in anaerobic digesters with sludge as feed was unknown a sup-




The potential for improving the sludge quality by reduction of harmful contaminants during 
anaerobic digestion or pasteurization at 70°C seems to be low. 
Pharmaceutical residues are generally not reduced during digestion at any investigated 
temperature (35, 55 and 60°C) or by pasteurization (70°C for 1 hour). In individual cases, 
some reduction occurs but this cannot be determined due to the low accuracy when analysing 
sludge samples. PAHs were generally not reduced during digestion or pasteurization, but were 
reduced to some extent (up to 60%) during digestion in three individual cases (indeno[1,2,3-









































Reduction of indeno[1,2,3-cd]pyrene +
dibenzo[a,h]antracene 
24 h 6 h 2.5 h 2 h
at 35 and 55°C resulted in about the same order of reduction of the three individual PAHs 
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